awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q34469183-ADC180A1-BF1D-4F15-853C-A074FB443100
Q34469183-ADC180A1-BF1D-4F15-853C-A074FB443100
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34469183-ADC180A1-BF1D-4F15-853C-A074FB443100
Observational study to evaluate the safety and efficacy of saroglitazar in Indian diabetic dyslipidemia patients
P2860
Q34469183-ADC180A1-BF1D-4F15-853C-A074FB443100
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34469183-ADC180A1-BF1D-4F15-853C-A074FB443100
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
63bee7286b9746d13b734398786ec78ca4182738
P2860
A multicenter, prospective, randomized, double-blind study to evaluate the safety and efficacy of Saroglitazar 2 and 4 mg compared with placebo in type 2 diabetes mellitus patients having hypertriglyceridemia not controlled with atorvastatin therapy